Cargando…

A comparison of the effects of Chinese non-pharmaceutical therapies for premature ovarian failure: A PRISMA-compliant systematic review and network meta-analysis

BACKGROUND: Premature ovarian failure (POF) is commonly treated with hormone replacement therapy (HRT). Many patients with POF choose acupuncture as a complementary therapy over HRT, due to possible adverse reactions. This systematic review and network meta-analysis (NMA) compares the efficacy of di...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jinhuan, Huang, Xingxian, Liu, Yongfeng, He, Yuhai, Yu, Haibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328983/
https://www.ncbi.nlm.nih.gov/pubmed/32590807
http://dx.doi.org/10.1097/MD.0000000000020958
_version_ 1783552828739944448
author Zhang, Jinhuan
Huang, Xingxian
Liu, Yongfeng
He, Yuhai
Yu, Haibo
author_facet Zhang, Jinhuan
Huang, Xingxian
Liu, Yongfeng
He, Yuhai
Yu, Haibo
author_sort Zhang, Jinhuan
collection PubMed
description BACKGROUND: Premature ovarian failure (POF) is commonly treated with hormone replacement therapy (HRT). Many patients with POF choose acupuncture as a complementary therapy over HRT, due to possible adverse reactions. This systematic review and network meta-analysis (NMA) compares the efficacy of different forms of acupuncture therapies for POF. METHODS: Seven databases including PubMed, the Cochrane Library, Embase, Wanfang database, China National Knowledge Infrastructure database, VIP Chinese Science, and Chinese Biomedical Database were searched for randomized controlled trials (RCTs) of various acupuncture treatments for POF. This time spanned from the date of database inception to January 13, 2020. RevMan 5.3 was used to assess the bias risk of the studies. A NMA of the included studies was performed using Stata14.0. RESULTS: A total of 408 items were searched in this study, and finally this NMA included 16 RCTS, involving 1,307 patients. It showed that acupuncture (OR:1.35,95%1.24 to 1.47) has the best effectiveness among the four acupuncture (standardized mean difference [SMD]-16.30,95% −31.33 to −1.28) is the most effective and the best in reducing follicle-stimulating hormone levels among the four acupuncture treatments. Acupuncture (SMD 26.67,95%5.95 to 47.40) and acupoint embedding (SMD41.14,95%11.90 to 70.37) were ranked in the top 2 positions, in improving estradiol, whereas acupuncture (SMD-4.90,95% −8.10 to −1.70) was than acupoint embedding and HRT, in reducing luteinizing hormone level. In addition, our conclusions have not changed significantly after the sensitivity analysis. Protocol registration number: CRD42020150508. CONCLUSION: With clinical evidence summarized by NMA, it is observed that acupuncture is the most promising therapy for improving menopausal symptoms, decreasing serum follicle-stimulating hormone and luteinizing hormone level. Therefore, acupuncture could be effective for patients with POF, who are intolerant to the adverse effects of hormone replacement therapy or who would prefer non-drug therapies. Further multi-center and high-quality RCT studies should be conducted to make our conclusion more rigorous.
format Online
Article
Text
id pubmed-7328983
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-73289832020-07-09 A comparison of the effects of Chinese non-pharmaceutical therapies for premature ovarian failure: A PRISMA-compliant systematic review and network meta-analysis Zhang, Jinhuan Huang, Xingxian Liu, Yongfeng He, Yuhai Yu, Haibo Medicine (Baltimore) 3800 BACKGROUND: Premature ovarian failure (POF) is commonly treated with hormone replacement therapy (HRT). Many patients with POF choose acupuncture as a complementary therapy over HRT, due to possible adverse reactions. This systematic review and network meta-analysis (NMA) compares the efficacy of different forms of acupuncture therapies for POF. METHODS: Seven databases including PubMed, the Cochrane Library, Embase, Wanfang database, China National Knowledge Infrastructure database, VIP Chinese Science, and Chinese Biomedical Database were searched for randomized controlled trials (RCTs) of various acupuncture treatments for POF. This time spanned from the date of database inception to January 13, 2020. RevMan 5.3 was used to assess the bias risk of the studies. A NMA of the included studies was performed using Stata14.0. RESULTS: A total of 408 items were searched in this study, and finally this NMA included 16 RCTS, involving 1,307 patients. It showed that acupuncture (OR:1.35,95%1.24 to 1.47) has the best effectiveness among the four acupuncture (standardized mean difference [SMD]-16.30,95% −31.33 to −1.28) is the most effective and the best in reducing follicle-stimulating hormone levels among the four acupuncture treatments. Acupuncture (SMD 26.67,95%5.95 to 47.40) and acupoint embedding (SMD41.14,95%11.90 to 70.37) were ranked in the top 2 positions, in improving estradiol, whereas acupuncture (SMD-4.90,95% −8.10 to −1.70) was than acupoint embedding and HRT, in reducing luteinizing hormone level. In addition, our conclusions have not changed significantly after the sensitivity analysis. Protocol registration number: CRD42020150508. CONCLUSION: With clinical evidence summarized by NMA, it is observed that acupuncture is the most promising therapy for improving menopausal symptoms, decreasing serum follicle-stimulating hormone and luteinizing hormone level. Therefore, acupuncture could be effective for patients with POF, who are intolerant to the adverse effects of hormone replacement therapy or who would prefer non-drug therapies. Further multi-center and high-quality RCT studies should be conducted to make our conclusion more rigorous. Wolters Kluwer Health 2020-06-26 /pmc/articles/PMC7328983/ /pubmed/32590807 http://dx.doi.org/10.1097/MD.0000000000020958 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 3800
Zhang, Jinhuan
Huang, Xingxian
Liu, Yongfeng
He, Yuhai
Yu, Haibo
A comparison of the effects of Chinese non-pharmaceutical therapies for premature ovarian failure: A PRISMA-compliant systematic review and network meta-analysis
title A comparison of the effects of Chinese non-pharmaceutical therapies for premature ovarian failure: A PRISMA-compliant systematic review and network meta-analysis
title_full A comparison of the effects of Chinese non-pharmaceutical therapies for premature ovarian failure: A PRISMA-compliant systematic review and network meta-analysis
title_fullStr A comparison of the effects of Chinese non-pharmaceutical therapies for premature ovarian failure: A PRISMA-compliant systematic review and network meta-analysis
title_full_unstemmed A comparison of the effects of Chinese non-pharmaceutical therapies for premature ovarian failure: A PRISMA-compliant systematic review and network meta-analysis
title_short A comparison of the effects of Chinese non-pharmaceutical therapies for premature ovarian failure: A PRISMA-compliant systematic review and network meta-analysis
title_sort comparison of the effects of chinese non-pharmaceutical therapies for premature ovarian failure: a prisma-compliant systematic review and network meta-analysis
topic 3800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328983/
https://www.ncbi.nlm.nih.gov/pubmed/32590807
http://dx.doi.org/10.1097/MD.0000000000020958
work_keys_str_mv AT zhangjinhuan acomparisonoftheeffectsofchinesenonpharmaceuticaltherapiesforprematureovarianfailureaprismacompliantsystematicreviewandnetworkmetaanalysis
AT huangxingxian acomparisonoftheeffectsofchinesenonpharmaceuticaltherapiesforprematureovarianfailureaprismacompliantsystematicreviewandnetworkmetaanalysis
AT liuyongfeng acomparisonoftheeffectsofchinesenonpharmaceuticaltherapiesforprematureovarianfailureaprismacompliantsystematicreviewandnetworkmetaanalysis
AT heyuhai acomparisonoftheeffectsofchinesenonpharmaceuticaltherapiesforprematureovarianfailureaprismacompliantsystematicreviewandnetworkmetaanalysis
AT yuhaibo acomparisonoftheeffectsofchinesenonpharmaceuticaltherapiesforprematureovarianfailureaprismacompliantsystematicreviewandnetworkmetaanalysis
AT zhangjinhuan comparisonoftheeffectsofchinesenonpharmaceuticaltherapiesforprematureovarianfailureaprismacompliantsystematicreviewandnetworkmetaanalysis
AT huangxingxian comparisonoftheeffectsofchinesenonpharmaceuticaltherapiesforprematureovarianfailureaprismacompliantsystematicreviewandnetworkmetaanalysis
AT liuyongfeng comparisonoftheeffectsofchinesenonpharmaceuticaltherapiesforprematureovarianfailureaprismacompliantsystematicreviewandnetworkmetaanalysis
AT heyuhai comparisonoftheeffectsofchinesenonpharmaceuticaltherapiesforprematureovarianfailureaprismacompliantsystematicreviewandnetworkmetaanalysis
AT yuhaibo comparisonoftheeffectsofchinesenonpharmaceuticaltherapiesforprematureovarianfailureaprismacompliantsystematicreviewandnetworkmetaanalysis